medigraphic.com
Boletín Médico del Hospital Infantil de México

2012, Número 5

<< Anterior Siguiente >>

Bol Med Hosp Infant Mex 2012; 69 (5)


Participación de la prolactina en la respuesta inmune

Blanco FF, Legorreta HMV, Huerta VYR, Chávez RK, Montoya DE, Chávez-Sánchez L, Zenteno GE

Idioma: Español
Referencias bibliográficas: 74
Paginas: 329-336
Archivo PDF: 753.17 Kb.


RESUMEN

Existen evidencias de la relación entre el sistema inmune y el endócrino vía múltiples factores de comunicación, como citocinas, neuropéptidos, neurotransmisores y hormonas. Se ha demostrado la participación de la hormona prolactina en la respuesta inmune innata y adaptativa. Además de ser producida por la glándula pituitaria, también es producida y secretada por las células del sistema inmunológico. El objetivo de esta revisión fue puntualizar acerca de la participación de la prolactina secretada por estas células en la respuesta inmune.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Gala RR. Prolactin and growth hormone in the regulation of the immune system. Proc Soc Exp Biol Med 1991;198:513-527.

  2. Reber PM. Prolactin and immunomodulation. Am J Med 1993;5:637-644.

  3. Yu-Lee LY, Luo G, Book ML, Morris SM. Lactogenic hormone signal transduction. Biol Reprod 1998;58:295-301.

  4. Horseman ND, Zhao W, Montecino Rodriguez E, Tanaka M, Nakashima K, Engle SJ, et al. Defective mammopoiesis, but normal hematopoiesis, in mice with target disruption of the prolactine gene. EMBO J 1997;16:6926-6935.

  5. Maslar IA, Riddick DH. Prolactin production by human endometrium during the normal menstrual cycle. Am J Obstet Gynecol 1979;135:751-754.

  6. Lee DW, Markoff E. Synthesis and release of glycosylated prolactin by human decidua in vitro. J Clin Endocrinol Metab 1986;62:990-994.

  7. Montgomery DW, Zukoski CF, Shah GN, Buckley AR, Pacholczyk T, Russell DH. Concanavalin A-stimulated murine splenocytes produce a factor with prolactin-like bioactivity and immunoreactivity. Biochem Biophys Res Commun 1987;145:692-698.

  8. Freeman M, Kanycska B, Lerant A, Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000;80:1523-1631.

  9. Hiestand PC, Mekler P, Nordmann R, Grieder A, Permmongkol C. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. Proc Natl Acad Sci USA 1986;83:2599-2603.

  10. Pellegrini I, Lebrun J-J, Ali S, Kelly PA. Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol 1992;6:1023-1031.

  11. DiMattia GE, Gellersen B, Duckworth ML, Friesen HG. Human prolactin gene expression. The use of an alternative non coding exon in decidual and the IM-9-P3 lymphoblast cell line. J Biol Chem 1990;265:16412-16421.

  12. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: actions signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 1998;19:225-268.

  13. Yu-Lee LY. Prolactin modulation of immune and inflammatory responses. Recent Prog Horm Res 2002;57:435-455.

  14. Goffin V, Binart N, Touraine P, Kelly PA. Prolactin: the new biology of an old hormone. Annu Rev Physiol 2002;64:47-67.

  15. Méndez I, Cariño C, Díaz L. Prolactin in the immunological system: synthesis and biological effects. Rev Invest Clin 2005;57:447-456.

  16. Matera L. Endocrine, paracrine and autocrin actions of prolactin on immune cells. Life Sci 1996;59:599-614.

  17. Montgomery DW. Prolactin production by immune cells. Lupus 2001;10:665-675.

  18. Nicoll CS, Mayer GL, Russell SM. Structural features of prolactin and growth hormones that can be related to their biological properties. Endocr Rev 1986;7:169-203.

  19. Matera L. Action of pituitary and lymphocyte prolactin. Neuroimmunomodulation 1997;4:171-180.

  20. Brue T, Caruso E, Marange I, Hoffmann T, Evrin M, Gunz G, et al. Immunoradiometric analysis of circulating human glycosilated and nonglycosilated prolactin forms: spontaneous and stimulated secretions. J Clin Endocrinol Metab 1992;75:1338-1344.

  21. Fahie-Wilson MN, John R, Ellis AR. Macroprolactin; high molecular mass forms of circulating prolactin. Ann Clin Biochem 2005;42:175-192.

  22. Leaños A, Pascoe D, Fraga A, Blanco-Favela F. Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia. Lupus 1998;7:398-403.

  23. Ferrara N, Clapp C, Weiner R. The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocrinology 1991;129:896-900.

  24. Troung AT, Duez C, Belayew A, Renard A, Pictet R, Bell GI, et al. Isolation and characterization of the human prolactin gene. EMBO J 1984;3:429-437.

  25. Goffin V, Shiverick KT, Kell PA, Martial JA. Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen and related proteins in mammals. Endocrinol Rev 1996;17:385-410.

  26. Owerbach D, Rutter WJ, Cooke NE, Martial JA, Shows TB. The prolactin gene is located on chromosome 6 in humans. Science 1981;212:815-816.

  27. Bazan JF. A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain. Biochem Biophys Res Commun 1989;164:788-795.

  28. DiMattia GE, Gellersen B, Bohnet HG, Friesen HG. A human B-lymphoblastoid cell line produces prolactin. Endocrinology 1988;122:2508-2517.

  29. Tan D, Walker A. Short form 1b human prolactin receptor down-regulates expression of the long form. J Mol Endocrinol 2010;44:187-194.

  30. Binart N, Barchelot A, Bouilly J. Impact of prolactin receptor isoforms on reproduction. Trends Endocrinol Metab 2010;21:362-368.

  31. Maeda H, Izumi S, Kato Y, Cai LY, Kato T, Suzuki T, et al. Gene expression of lymphocyte prolactin receptor was suppressed in lactating mothers. Tokai J Exp Clin Med 2010;35:62-65.

  32. Broutin I, Jomain JB, Tallet E, van Agthoven J, Raynal B, Hoos S, et al. Crystal structure of an affinity-matured prolactin complexed to its dimerized receptor reveals the topology of hormone binding site 2. J Biol Chem 2010;285:8422-8433.

  33. Dardenne M, de Morales MC, Kelly PA, Gagnerault MC. Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytofluorometry. Endocrinology 1994;134:2108-2114.

  34. Clevenger CV, Freier DO, Kline JB. Prolactin receptor signal transduction in cell of the immune system. J Endocrinol 1998;157:187-197.

  35. Xie YL, Hassan SA, Qazi AM, Tsai-Morris CH, Dufau ML. Intramolecular disulfide bonds of the prolactin receptor short form are required for its inhibitory action on the function of the long form of the receptor. Mol Cell Biol 2009;29:2546-2555.

  36. Yu-Lee LY. Molecular actions of prolactin in the immune system. Proc Soc Exp Biol Med 1997;215:35-52.

  37. Ben-Jonathan N, LaPensee CR, LaPensee EW. What can we learn from rodents about prolactin in humans? Endocr Rev 2008;29:1-41.

  38. Too CK. Induction of Sp1 activity by prolactin and interleukin-2 in Nb2 T cells: differential association of Sp1-DNA complexes with Stats. Mol Cell Endocrinol 1997;129:7-16.

  39. Gilmour KC, Reich NC. Receptor to nucleus signaling by prolactin and interleukin 2 via activation of latent DNA-binding factors. Proc Natl Acad Sci USA 1994;91:6850-6854.

  40. Schindler C, Darnell JE Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 1995;64:621-651.

  41. Tomio A, Schust DJ, Kawana K, Yasugi T, Kawana Y, Mahalingaiah S, et al. Prolactin can modulate CD4+ T-cell response through receptor-mediated alterations in the expression of T-bet. Immunol Cell Biol 2008;86:616-621.

  42. Smith PE. The effect of hypophysectomy upon the involution of the thymus in the rat. Anatom Rec 1930;47:119-129.

  43. Nagy E, Berczi I. Immunodeficiency in hypophysectomized rats. Acta Endocrinol (Copenh) 1978;89:530-537.

  44. Nagy E, Berczi I, Wren GE, Asa SL, Kovacs K. Immunomodulation by bromocriptine. Immunopharmacology 1983;6:231-243.

  45. Spangelo BL, Macleod RM. The role immunopeptides in the regulation of anterior pituitary hormone release. Trends Endocrinol Metab 1990;1:408-412.

  46. Theas MS, De Laurentis A, Lasaga M, Pisera D, Duvilanski BH, Seilcovich A. Effect of lipopolysaccharide on tumor necrosis factor and prolactin release from rat anterior pituitary cells. Endocrine 1998;8:241-245.

  47. Wu H, Devi R, Malarkey WB. Expression and localization of prolactin messenger ribonucleic acid in the human immune system. Endocrinology 1996;137:349-353.

  48. Gubbay O, Critchley HO, Bowen JM, King A, Jabbour HN. Prolactin induces ERK phosphorylation in epithelial and CD56 (+) natural killer cells of the human endometrium. J Clin Endocrinol Metab 2002;87:2329-2335.

  49. Kelley KW, Weigent DA, Kooijman R. Protein hormones and immunity. Brain Behav Immun 2007;21:384-392.

  50. Sun R, Li AL, Wei HM, Tian ZG. Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines. Cell Res 2004;14:67-73.

  51. Sun R, Gault RA, Welniak LA, Tian ZG, Richards S, Murphy WJ. Immunologic and hematopoietic effects of recombinant human prolactin after syngeneic bone marrow transplantation in mice. Biol Blood Marrow Transplant 2003;9:426-434.

  52. Bouchard B, Ormandy C, Di Santo JP, Kelly PA. Immune system development and function in prolactin receptor-deficient mice. J Immunol 1999;163:576-582.

  53. Morales P, Carretero MV, Geronimo H, Copín SG, Gaspar ML, Marcos MA, et al. Influence of prolactin on the differentiation of mouse B-lymphoid precursors. Cell Grow Differ 1999;10:583-590.

  54. Chávez-Rueda K, Hernández J, Zenteno E, Leaños-Miranda A, Legorreta-Haquet MV, Blanco-Favela F. Identification of prolactin as a novel immunomodulator on the expression of co-stimulatory molecules and cytokine secretions on T and B human lymphocytes. Clin Immunol 2005;116:182-191.

  55. Yang L, Hu Y, Li X, Zhao J, Hou Y. Prolactin modulates the functions of murine spleen CD11c-positive dendritic cells. Int Immunopharmacol 2006;6:1478-1486.

  56. Takizawa K, Kitani S, Takeuchi F, Yamamoto K. Enhanced expression of CD69 and CD25 antigen on human peripheral blood mononuclear cells by prolactin. Endocr J 2005;52:635- 641.

  57. Chávez-Rueda K, Legorreta-Haquet MV, Cervera-Castillo H, Sánchez L, Jara LJ, Zenteno E, et al. Prolactin effect on CD69 and CD154 expression by CD4+ cells from systemic lupus erythematosus patients. Clin Exp Rheumatol 2005;23:769-777.

  58. Brand JM, Frohn C, Cziupka K, Brockmann C, Kirchner H, Luhm J. Prolactin triggers pro-inflammatory immune responses in peripheral immune cells. Eur Cytokine Netw 2004;15:99-104.

  59. Gerlo S, Veerdood P, Hooghe-Peters EL, Kooijman R. Modulation of prolactin expression in human T lymphocytes by cytokines. J Neuroimmunol 2005;162:190-193.

  60. Hartmann DP, Holaday JW, Bernton EW. Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB J 1989;3:2194-2202.

  61. Clevenger CV, Russell DH, Appasamy PM, Prystowsky MB. Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin. Proc Nati Acad Sci USA 1990;87:6460-6464.

  62. Fernández ML, Iglesias MM, Biron VA, Wolfenstein-Todel C. Protective effect of prolactin and placental lactogen on NOinduced Nb2 lymphoma cell apoptosis. Arch Biochem Biophys 2003;416:249-256.

  63. Minn AJ, Vélez P, Schendel SL, Liang H, Muchmore SW, Fesik SW, et al. Bcl-xL forms an ion channel in synthetic lipid membranes. Nature 1997;385:353-357.

  64. Mukherjee P, Mastro M, Hymer WC. Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. Endocrinology 1990;126:88-94.

  65. Buckley AR, Buckley DJ. Prolactin regulation of apoptosisassociated gene expression in T cells. Ann NY Acad Sci 2000;917:522-533.

  66. Carreño PC, Sacedón R, Jiménez E, Vicente A, Zapata AG. Prolactin affects both survival and differentiation of T-cell progenitors. J Neuroimmunol 2005;160:135-145.

  67. Xu D, Lin L, Lin X, Huang Z, Lei Z. Immunoregulation of autocrine prolactin: suppressing the expression of costimulatory molecules and cytokines in T lymphocytes by prolactin receptor knockdown. Cell Immunol 2010;263:71-78.

  68. Legorreta-Haquet MV, Chávez-Rueda K, Montoya-Díaz E, Arriaga-Pizano L, Silva-García R, Chávez-Sánchez L, et al. Prolactin down-regulates CD4+CD25hiCD127low/- regulatory T cell function in humans. J Mol Endocrinol 2012;48:77-85.

  69. Le NT, Chao N. Regulating regulatory T cells. Bone Marrow Transplant 2007;39:1-9.

  70. Murphy K, Travers P, Walport M, Janeway C. Janeway’s Immunobiology. Michigan: Garland Science; 2008.

  71. Sojka DK, Huang YH, Fowell DJ. Mechanisms of regulatory T-cell suppression —a diverse arsenal for moving target. Immunology 2008;124:13-22.

  72. Damoiseaux J. Regulatory T cells: back to the future. Neth J Med 2006;64:4-9.

  73. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008;133:775-787.

  74. Dimitrov S, Lange T Fehm HL, Born J. A regulatory role of prolactin, growth hormone, and corticosteroids for human T-cell production of cytokines. Brain Behav Immun 2004;18:368-374.




2020     |     www.medigraphic.com